Salicylic acid (SA)‐eluting bone regeneration scaffolds with interconnected porosity and local and sustained SA release
Source abstract
Abstract
Abstract In previous work, we observed that localized and sustained delivery of an anti‐inflammatory drug, salicylic acid (SA), via a SA‐based polymer (SAP) powder significantly enhanced diabetic bone regeneration through long‐term mitigation of local inflammation. In this study, SAP was formulated into uniform microspheres and then sintered into a scaffold with an interconnected porous structure and modulus suitable for bone regeneration. The SAP scaffolds have ∼45% SA loading, which is the highest among drug‐eluting bone regeneration scaffolds to‐date. In addition, the scaffold provides localized, controlled and sustained SA release that has been proven to enhance diabetic bone regeneration. With the combination of physical (interconnected porosity) and chemical therapeutic features (high drug loading and sustained release), the novel SAP scaffolds offer unique therapeutic advantages and are promising diabetic bone regeneration candidates. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 311–318, 2017.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Advanced Drug Delivery Systems · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering Rutgers, The State University of New Jersey Piscataway New Jersey 08854
Department of Pharmaceutics, Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey Piscataway New Jersey 08854
Department of Chemistry and Chemical Biology Rutgers, The State University of New Jersey Piscataway New Jersey 08854
Department of Materials Science Engineering ENSIACET 31030 Toulouse France
Funding
NIH · Rutgers Aresty
References (48)
Show source-provided references
1. AAOS Half of all musculoskeletal injuries occur in home 2009. Available at:http://www.aaos.org/news/aaosnow/apr09/clinical9.asp.
2. Surgeryenclyclopedia Tooth extraction 2015. Available at:http://www.surgeryencyclopedia.com/St-Wr/Tooth-Extraction.html.
3. The influence of diabetes mellitus on the healing of closed fractures10.1097/00003086-198807000-00028 ↗
4. 10.1016/j.jse.2009.11.04510.1016/j.jse.2009.11.045 ↗
5. 10.2337/diabetes.52.6.150210.2337/diabetes.52.6.1502 ↗
6. Surgeons A.AO.O. OrthoInfo—Treatment. Available at:http://orthoinfo.aaos.org/topic.cfm?topic=A00374 2015.
7. 10.1210/en.2002-22007210.1210/en.2002-220072 ↗
8. 10.1096/fj.11-19627910.1096/fj.11-196279 ↗
9. 10.1016/j.jacc.2005.06.00710.1016/j.jacc.2005.06.007 ↗
10. Prevention C.O.D.C.A.National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States C.f.D.C.a.P. US Department of Health and Human Services Editor2011: Atlanta GA.
11. 10.1097/TA.0b013e318256a15010.1097/TA.0b013e318256a150 ↗
12. 10.3310/hta1130010.3310/hta11300 ↗
13. 10.3171/foc.2002.13.6.510.3171/foc.2002.13.6.5 ↗
14. 10.1016/j.jconrel.2013.06.02410.1016/j.jconrel.2013.06.024 ↗
15. 10.1615/CritRevTherDrugCarrierSyst.201501124610.1615/CritRevTherDrugCarrierSyst.2015011246 ↗
16. 10.1016/j.actbio.2014.01.01610.1016/j.actbio.2014.01.016 ↗
17. Drug‐eluting scaffold to deliver chemotherapeutic medication for management of pancreatic cancer after surgery
18. 10.1016/j.drudis.2013.11.00710.1016/j.drudis.2013.11.007 ↗
19. 10.2174/2210304x1120204000310.2174/2210304x11202040003 ↗
20. 10.1002/adhm.20150043910.1002/adhm.201500439 ↗
21. 10.1002/smll.20080185510.1002/smll.200801855 ↗
22. 10.1016/j.msec.2015.07.01610.1016/j.msec.2015.07.016 ↗
23. 10.1016/j.actbio.2013.11.00210.1016/j.actbio.2013.11.002 ↗
24. 10.1016/j.biomaterials.2015.02.00610.1016/j.biomaterials.2015.02.006 ↗
25. 10.1002/mabi.20140047210.1002/mabi.201400472 ↗
26. 10.1186/s40824-015-0040-410.1186/s40824-015-0040-4 ↗
27. 10.1016/j.polymdegradstab.2015.02.00210.1016/j.polymdegradstab.2015.02.002 ↗
28. 10.1126/science.288.5463.11310.1126/science.288.5463.113 ↗
29. Polarity Index. 2015 07/31/15 [cited 2015 09/11/2015]; Available at:http://macro.lsu.edu/howto/solvents/polarity%20index.htm .
30. 10.1021/ac034671210.1021/ac0346712 ↗
31. 10.1177/088391151246460510.1177/0883911512464605 ↗
32. 10.1021/ma048051u10.1021/ma048051u ↗
33. 10.1002/marc.20090002910.1002/marc.200900029 ↗
34. 10.1016/S0142-9612(00)00073-910.1016/S0142-9612(00)00073-9 ↗
35. 10.1021/ma048051u10.1021/ma048051u ↗
36. 10.1002/jbm.a.3470610.1002/jbm.a.34706 ↗
37. Fracture healing perspectives10.1097/00003086-198511000-00019 ↗
38. 10.1002/mabi.20140023810.1002/mabi.201400238 ↗
39. 10.1002/jbm.b.3332110.1002/jbm.b.33321 ↗
40. 10.1016/j.actbio.2015.01.03110.1016/j.actbio.2015.01.031 ↗
41. 10.1063/1.279078510.1063/1.2790785 ↗
42. 10.1016/j.biomaterials.2005.02.00210.1016/j.biomaterials.2005.02.002 ↗
43. SuzukiTSO.Interface Oral Health Science. Proceedings of the 3rd international symposium for Interface Oral Health Science ed. P.S.K.S.N.T.T.K.M.A.T.H.C. Margolis.2009: Springer Science & Business Media.
44. 10.1371/journal.pone.012575710.1371/journal.pone.0125757 ↗
45. 10.1016/j.bone.2015.04.02410.1016/j.bone.2015.04.024 ↗
46. 10.1111/joa.1226210.1111/joa.12262 ↗
47. 10.2337/db11-093110.2337/db11-0931 ↗
48. 10.1172/JCI1155910.1172/JCI11559 ↗